(4-((4-Bromophenyl)sulfonyl)piperazin-1-yl)(1-(4-iodobenzyl)-1H-1,2,3-triazol-4-yl)methanone

ID: ALA4756332

PubChem CID: 162655539

Max Phase: Preclinical

Molecular Formula: C20H19BrIN5O3S

Molecular Weight: 616.28

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1cn(Cc2ccc(I)cc2)nn1)N1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1

Standard InChI:  InChI=1S/C20H19BrIN5O3S/c21-16-3-7-18(8-4-16)31(29,30)27-11-9-25(10-12-27)20(28)19-14-26(24-23-19)13-15-1-5-17(22)6-2-15/h1-8,14H,9-13H2

Standard InChI Key:  WFBLKTSZKKKEIY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   29.1465  -12.1341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.7420  -11.4242    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   28.3289  -12.1315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4560  -10.1901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4560  -11.0114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.1654  -11.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8707  -11.0114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8707  -10.1901    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.1654   -9.7774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5837   -9.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2944  -10.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5861   -8.9623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.3771  -11.0081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.1801  -11.1845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5949  -10.4738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0457   -9.8609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4128  -10.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8240  -11.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4131  -11.8882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8236  -12.5980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6458  -12.5955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0557  -11.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6387  -11.1702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0324  -11.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0342  -10.1932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3226   -9.7857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6103  -10.1953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6142  -11.0209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3263  -11.4288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0573  -13.3015    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   25.9020   -9.7878    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 11  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  5  2  1  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 21 30  1  0
 27 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4756332

    ---

Associated Targets(Human)

BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 616.28Molecular Weight (Monoisotopic): 614.9437AlogP: 2.84#Rotatable Bonds: 5
Polar Surface Area: 88.40Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.41Np Likeness Score: -2.49

References

1. Manasa, Kesari Lakshmi, Thatikonda, Sowjanya, Sigalapalli, Dilep Kumar, Vuppaladadium, Sowmya, Devi, Ganthala Parimala, Godugu, Chandraiah, Alvala, Mallika, Nagesh, Narayana, Babu, Bathini Nagendra.  (2020)  Design and synthesis of substituted (1-(benzyl)-1H-1,2,3-triazol-4-yl)(piperazin-1-yl)methanone conjugates: study on their apoptosis inducing ability and tubulin polymerization inhibition,  11  (11): [PMID:34095841] [10.1039/d0md00162g]

Source